-
1
-
-
17144432813
-
The prime-boost concept applied to HIV preventive vaccines
-
Excler J.L., and Plotkin S. The prime-boost concept applied to HIV preventive vaccines. Aids 11 Suppl. A (1997) S127-S137
-
(1997)
Aids
, vol.11
, Issue.SUPPL. A
-
-
Excler, J.L.1
Plotkin, S.2
-
2
-
-
0034176364
-
The prime-boost strategy: exciting prospects for improved vaccination
-
Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 (2000) 163-165
-
(2000)
Immunol Today
, vol.21
, pp. 163-165
-
-
Ramshaw, I.A.1
Ramsay, A.J.2
-
3
-
-
33751071573
-
Combination DNA plus protein HIV vaccines
-
Lu S. Combination DNA plus protein HIV vaccines. Springer Semin Immunopathol 28 (2006) 255-265
-
(2006)
Springer Semin Immunopathol
, vol.28
, pp. 255-265
-
-
Lu, S.1
-
4
-
-
0026519706
-
Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160
-
First major report on the use of heterologous prime-boost vaccination approach, in the context of AIDS vaccine development.
-
Hu S.L., Abrams K., Barber G.N., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., and Benveniste R.E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255 (1992) 456-459. First major report on the use of heterologous prime-boost vaccination approach, in the context of AIDS vaccine development.
-
(1992)
Science
, vol.255
, pp. 456-459
-
-
Hu, S.L.1
Abrams, K.2
Barber, G.N.3
Moran, P.4
Zarling, J.M.5
Langlois, A.J.6
Kuller, L.7
Morton, W.R.8
Benveniste, R.E.9
-
5
-
-
0025820906
-
Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160
-
Hu S.L., Klaniecki J., Dykers T., Sridhar P., and Travis B.M. Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Res Hum Retroviruses 7 (1991) 615-620
-
(1991)
AIDS Res Hum Retroviruses
, vol.7
, pp. 615-620
-
-
Hu, S.L.1
Klaniecki, J.2
Dykers, T.3
Sridhar, P.4
Travis, B.M.5
-
6
-
-
0025965050
-
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
-
Girard M., Kieny M.P., Pinter A., Barre-Sinoussi F., Nara P., Kolbe H., Kusumi K., Chaput A., Reinhart T., Muchmore E., et al. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci U S A 88 (1991) 542-546
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 542-546
-
-
Girard, M.1
Kieny, M.P.2
Pinter, A.3
Barre-Sinoussi, F.4
Nara, P.5
Kolbe, H.6
Kusumi, K.7
Chaput, A.8
Reinhart, T.9
Muchmore, E.10
-
7
-
-
0023912632
-
A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS
-
Zagury D., Bernard J., Cheynier R., Desportes I., Leonard R., Fouchard M., Reveil B., Ittele D., Lurhuma Z., Mbayo K., et al. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature 332 (1988) 728-731
-
(1988)
Nature
, vol.332
, pp. 728-731
-
-
Zagury, D.1
Bernard, J.2
Cheynier, R.3
Desportes, I.4
Leonard, R.5
Fouchard, M.6
Reveil, B.7
Ittele, D.8
Lurhuma, Z.9
Mbayo, K.10
-
8
-
-
0020517993
-
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
-
Emini E.A., Jameson B.A., and Wimmer E. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304 (1983) 699-703
-
(1983)
Nature
, vol.304
, pp. 699-703
-
-
Emini, E.A.1
Jameson, B.A.2
Wimmer, E.3
-
10
-
-
0030872511
-
Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
-
Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., Walker C.M., and Steimer K.S. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15 (1997) 869-873
-
(1997)
Vaccine
, vol.15
, pp. 869-873
-
-
Barnett, S.W.1
Rajasekar, S.2
Legg, H.3
Doe, B.4
Fuller, D.H.5
Haynes, J.R.6
Walker, C.M.7
Steimer, K.S.8
-
11
-
-
0031657986
-
Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting
-
Richmond J.F., Lu S., Santoro J.C., Weng J., Hu S.L., Montefiori D.C., and Robinson H.L. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol 72 (1998) 9092-9100
-
(1998)
J Virol
, vol.72
, pp. 9092-9100
-
-
Richmond, J.F.1
Lu, S.2
Santoro, J.C.3
Weng, J.4
Hu, S.L.5
Montefiori, D.C.6
Robinson, H.L.7
-
12
-
-
21644445378
-
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
-
Beddows S., Schulke N., Kirschner M., Barnes K., Franti M., Michael E., Ketas T., Sanders R.W., Maddon P.J., Olson W.C., et al. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 79 (2005) 8812-8827
-
(2005)
J Virol
, vol.79
, pp. 8812-8827
-
-
Beddows, S.1
Schulke, N.2
Kirschner, M.3
Barnes, K.4
Franti, M.5
Michael, E.6
Ketas, T.7
Sanders, R.W.8
Maddon, P.J.9
Olson, W.C.10
-
13
-
-
19944393561
-
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1
-
Wang S., Arthos J., Lawrence J.M., Van Ryk D., Mboudjeka I., Shen S., Chou T.H., Montefiori D.C., and Lu S. Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1. J Virol 79 (2005) 7933-7937
-
(2005)
J Virol
, vol.79
, pp. 7933-7937
-
-
Wang, S.1
Arthos, J.2
Lawrence, J.M.3
Van Ryk, D.4
Mboudjeka, I.5
Shen, S.6
Chou, T.H.7
Montefiori, D.C.8
Lu, S.9
-
14
-
-
33746651142
-
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
-
By using DNA prime-protein boost vaccination to deliver polyvalent HIV-1 Env antigens, broadly reactive neutralizing antibodies are elicited in immunized sera in a rabbit model.
-
Wang S., Pal R., Mascola J.R., Chou T.H., Mboudjeka I., Shen S., Liu Q., Whitney S., Keen T., Nair B.C., et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 350 (2006) 34-47. By using DNA prime-protein boost vaccination to deliver polyvalent HIV-1 Env antigens, broadly reactive neutralizing antibodies are elicited in immunized sera in a rabbit model.
-
(2006)
Virology
, vol.350
, pp. 34-47
-
-
Wang, S.1
Pal, R.2
Mascola, J.R.3
Chou, T.H.4
Mboudjeka, I.5
Shen, S.6
Liu, Q.7
Whitney, S.8
Keen, T.9
Nair, B.C.10
-
15
-
-
33745496632
-
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype
-
Pal R., Kalyanaraman V.S., Nair B.C., Whitney S., Keen T., Hocker L., Hudacik L., Rose N., Mboudjeka I., Shen S., et al. Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype. Virology 348 (2006) 341-353
-
(2006)
Virology
, vol.348
, pp. 341-353
-
-
Pal, R.1
Kalyanaraman, V.S.2
Nair, B.C.3
Whitney, S.4
Keen, T.5
Hocker, L.6
Hudacik, L.7
Rose, N.8
Mboudjeka, I.9
Shen, S.10
-
16
-
-
39149109930
-
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
-
First report of inducing broadly reactive NAb in humans in addition to high-level cell-mediated immune responses using a polyvalent, multi-gene DNA prime-protein boost HIV vaccine.
-
Wang S., Kennedy J.S., West K., Montefiori D.C., Coley S., Lawrence J., Shen S., Green S., Rothman A.L., Ennis F.A., et al. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 26 (2008) 1098-1110. First report of inducing broadly reactive NAb in humans in addition to high-level cell-mediated immune responses using a polyvalent, multi-gene DNA prime-protein boost HIV vaccine.
-
(2008)
Vaccine
, vol.26
, pp. 1098-1110
-
-
Wang, S.1
Kennedy, J.S.2
West, K.3
Montefiori, D.C.4
Coley, S.5
Lawrence, J.6
Shen, S.7
Green, S.8
Rothman, A.L.9
Ennis, F.A.10
-
17
-
-
45749099294
-
Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration
-
When a DNA prime-protein boost HIV vaccine was tested in humans, the DNA priming effect delivered by intramuscular (IM) needle injection was more effective than the intradermal (ID) needle injection in eliciting HIV-1 antigen specific cell-mediated immune responses, which is contrary to the long-held hypothesis that ID route is more immunogenic than IM route for DNA vaccines.
-
Bansal A., Jackson B., West K., Wang S., Lu S., Kennedy J.S., and Goepfert P.A. Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration. J Virol 82 (2008) 6458-6469. When a DNA prime-protein boost HIV vaccine was tested in humans, the DNA priming effect delivered by intramuscular (IM) needle injection was more effective than the intradermal (ID) needle injection in eliciting HIV-1 antigen specific cell-mediated immune responses, which is contrary to the long-held hypothesis that ID route is more immunogenic than IM route for DNA vaccines.
-
(2008)
J Virol
, vol.82
, pp. 6458-6469
-
-
Bansal, A.1
Jackson, B.2
West, K.3
Wang, S.4
Lu, S.5
Kennedy, J.S.6
Goepfert, P.A.7
-
18
-
-
0035815437
-
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
-
•], this report showed that DNA prime-MVA viral vector boost approach was able to elicit protective immune response against SHIV in a non-human primate model.
-
•], this report showed that DNA prime-MVA viral vector boost approach was able to elicit protective immune response against SHIV in a non-human primate model.
-
(2001)
Science
, vol.292
, pp. 69-74
-
-
Amara, R.R.1
Villinger, F.2
Altman, J.D.3
Lydy, S.L.4
O'Neil, S.P.5
Staprans, S.I.6
Montefiori, D.C.7
Xu, Y.8
Herndon, J.G.9
Wyatt, L.S.10
-
19
-
-
0032815843
-
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
-
Hanke T., Samuel R.V., Blanchard T.J., Neumann V.C., Allen T.M., Boyson J.E., Sharpe S.A., Cook N., Smith G.L., Watkins D.I., et al. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen. J Virol 73 (1999) 7524-7532
-
(1999)
J Virol
, vol.73
, pp. 7524-7532
-
-
Hanke, T.1
Samuel, R.V.2
Blanchard, T.J.3
Neumann, V.C.4
Allen, T.M.5
Boyson, J.E.6
Sharpe, S.A.7
Cook, N.8
Smith, G.L.9
Watkins, D.I.10
-
20
-
-
0031772993
-
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
-
Kent S.J., Zhao A., Best S.J., Chandler J.D., Boyle D.B., and Ramshaw I.A. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 72 (1998) 10180-10188
-
(1998)
J Virol
, vol.72
, pp. 10180-10188
-
-
Kent, S.J.1
Zhao, A.2
Best, S.J.3
Chandler, J.D.4
Boyle, D.B.5
Ramshaw, I.A.6
-
21
-
-
0037122719
-
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
-
•], this is another key study reporting that the use of DNA prime-adeno viral vector boost approach was able to elicit protective immune responses against SHIV in a non-human primate model.
-
•], this is another key study reporting that the use of DNA prime-adeno viral vector boost approach was able to elicit protective immune responses against SHIV in a non-human primate model.
-
(2002)
Nature
, vol.415
, pp. 331-335
-
-
Shiver, J.W.1
Fu, T.M.2
Chen, L.3
Casimiro, D.R.4
Davies, M.E.5
Evans, R.K.6
Zhang, Z.Q.7
Simon, A.J.8
Trigona, W.L.9
Dubey, S.A.10
-
22
-
-
0041707861
-
Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines
-
Barouch D.H., McKay P.F., Sumida S.M., Santra S., Jackson S.S., Gorgone D.A., Lifton M.A., Chakrabarti B.K., Xu L., Nabel G.J., et al. Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines. J Virol 77 (2003) 8729-8735
-
(2003)
J Virol
, vol.77
, pp. 8729-8735
-
-
Barouch, D.H.1
McKay, P.F.2
Sumida, S.M.3
Santra, S.4
Jackson, S.S.5
Gorgone, D.A.6
Lifton, M.A.7
Chakrabarti, B.K.8
Xu, L.9
Nabel, G.J.10
-
23
-
-
23444460831
-
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus
-
Egan M.A., Chong S.Y., Megati S., Montefiori D.C., Rose N.F., Boyer J.D., Sidhu M.K., Quiroz J., Rosati M., Schadeck E.B., et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses 21 (2005) 629-643
-
(2005)
AIDS Res Hum Retroviruses
, vol.21
, pp. 629-643
-
-
Egan, M.A.1
Chong, S.Y.2
Megati, S.3
Montefiori, D.C.4
Rose, N.F.5
Boyer, J.D.6
Sidhu, M.K.7
Quiroz, J.8
Rosati, M.9
Schadeck, E.B.10
-
24
-
-
38749132973
-
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
-
Human study results showed that a DNA prime-pox vector boost HIV vaccine elicited higher level and better quality of cell-mediated immune responses in humans, when compared with a pox vector only HIV vaccine with the same antigens in both vaccines.
-
Harari A., Bart P.A., Stohr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T., et al. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J Exp Med 205 (2008) 63-77. Human study results showed that a DNA prime-pox vector boost HIV vaccine elicited higher level and better quality of cell-mediated immune responses in humans, when compared with a pox vector only HIV vaccine with the same antigens in both vaccines.
-
(2008)
J Exp Med
, vol.205
, pp. 63-77
-
-
Harari, A.1
Bart, P.A.2
Stohr, W.3
Tapia, G.4
Garcia, M.5
Medjitna-Rais, E.6
Burnet, S.7
Cellerai, C.8
Erlwein, O.9
Barber, T.10
-
25
-
-
20244383550
-
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
-
Nitayaphan S., Pitisuttithum P., Karnasuta C., Eamsila C., de Souza M., Morgan P., Polonis V., Benenson M., VanCott T., Ratto-Kim S., et al. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis 190 (2004) 702-706
-
(2004)
J Infect Dis
, vol.190
, pp. 702-706
-
-
Nitayaphan, S.1
Pitisuttithum, P.2
Karnasuta, C.3
Eamsila, C.4
de Souza, M.5
Morgan, P.6
Polonis, V.7
Benenson, M.8
VanCott, T.9
Ratto-Kim, S.10
-
26
-
-
33749235904
-
A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
-
Dunachie S.J., Walther M., Epstein J.E., Keating S., Berthoud T., Andrews L., Andersen R.F., Bejon P., Goonetilleke N., Poulton I., et al. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect Immun 74 (2006) 5933-5942
-
(2006)
Infect Immun
, vol.74
, pp. 5933-5942
-
-
Dunachie, S.J.1
Walther, M.2
Epstein, J.E.3
Keating, S.4
Berthoud, T.5
Andrews, L.6
Andersen, R.F.7
Bejon, P.8
Goonetilleke, N.9
Poulton, I.10
-
27
-
-
56849108004
-
rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector
-
Prime-boost approach with a bacterial vector and a viral vector for eliciting cell-mediated immune responses in a non-human primate model.
-
Magalhaes I., Sizemore D.R., Ahmed R.K., Mueller S., Wehlin L., Scanga C., Weichold F., Schirru G., Pau M.G., Goudsmit J., et al. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS ONE 3 (2008) e3790. Prime-boost approach with a bacterial vector and a viral vector for eliciting cell-mediated immune responses in a non-human primate model.
-
(2008)
PLoS ONE
, vol.3
-
-
Magalhaes, I.1
Sizemore, D.R.2
Ahmed, R.K.3
Mueller, S.4
Wehlin, L.5
Scanga, C.6
Weichold, F.7
Schirru, G.8
Pau, M.G.9
Goudsmit, J.10
-
28
-
-
33747613795
-
A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge
-
Cai H., Yu D.H., Hu X.D., Li S.X., and Zhu Y.X. A combined DNA vaccine-prime, BCG-boost strategy results in better protection against Mycobacterium bovis challenge. DNA Cell Biol 25 (2006) 438-447
-
(2006)
DNA Cell Biol
, vol.25
, pp. 438-447
-
-
Cai, H.1
Yu, D.H.2
Hu, X.D.3
Li, S.X.4
Zhu, Y.X.5
-
29
-
-
4143110222
-
Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting
-
Wang Q.M., Sun S.H., Hu Z.L., Yin M., Xiao C.J., and Zhang J.C. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting. Vaccine 22 (2004) 3622-3627
-
(2004)
Vaccine
, vol.22
, pp. 3622-3627
-
-
Wang, Q.M.1
Sun, S.H.2
Hu, Z.L.3
Yin, M.4
Xiao, C.J.5
Zhang, J.C.6
-
30
-
-
0032698408
-
DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model
-
Sin J.I., Bagarazzi M., Pachuk C., and Weiner D.B. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol 18 (1999) 771-779
-
(1999)
DNA Cell Biol
, vol.18
, pp. 771-779
-
-
Sin, J.I.1
Bagarazzi, M.2
Pachuk, C.3
Weiner, D.B.4
-
31
-
-
0034783743
-
Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine
-
Biswas S., Reddy G.S., Srinivasan V.A., and Rangarajan P.N. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. Hum Gene Ther 12 (2001) 1917-1922
-
(2001)
Hum Gene Ther
, vol.12
, pp. 1917-1922
-
-
Biswas, S.1
Reddy, G.S.2
Srinivasan, V.A.3
Rangarajan, P.N.4
-
32
-
-
33745369937
-
Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization
-
Herrmann J.E., Wang S., Zhang C., Panchal R.G., Bavari S., Lyons C.R., Lovchik J.A., Golding B., Shiloach J., and Lu S. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization. Vaccine 24 (2006) 5872-5880
-
(2006)
Vaccine
, vol.24
, pp. 5872-5880
-
-
Herrmann, J.E.1
Wang, S.2
Zhang, C.3
Panchal, R.G.4
Bavari, S.5
Lyons, C.R.6
Lovchik, J.A.7
Golding, B.8
Shiloach, J.9
Lu, S.10
-
33
-
-
13444288031
-
Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting
-
Xiao-wen H., Shu-han S., Zhen-lin H., Jun L., Lei J., Feng-juan Z., Ya-nan Z., and Ying-jun G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 23 (2005) 1649-1656
-
(2005)
Vaccine
, vol.23
, pp. 1649-1656
-
-
Xiao-wen, H.1
Shu-han, S.2
Zhen-lin, H.3
Jun, L.4
Lei, J.5
Feng-juan, Z.6
Ya-nan, Z.7
Ying-jun, G.8
-
34
-
-
45049083212
-
Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses
-
Heterologous DNA prime-inactivated flu vaccine boost is more effective than the homologous prime-boost with inactivated flu vaccine in eliciting protective antibody responses in an animal model naïve to flu antigen, pointing to new vaccination strategies against influenza viruses that may cause pandemic flu in the world human populations.
-
Wang S., Parker C., Taaffe J., Solorzano A., Garcia-Sastre A., and Lu S. Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26 (2008) 3626-3633. Heterologous DNA prime-inactivated flu vaccine boost is more effective than the homologous prime-boost with inactivated flu vaccine in eliciting protective antibody responses in an animal model naïve to flu antigen, pointing to new vaccination strategies against influenza viruses that may cause pandemic flu in the world human populations.
-
(2008)
Vaccine
, vol.26
, pp. 3626-3633
-
-
Wang, S.1
Parker, C.2
Taaffe, J.3
Solorzano, A.4
Garcia-Sastre, A.5
Lu, S.6
-
35
-
-
33847075902
-
In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer
-
Garcia-Hernandez Mde L., Gray A., Hubby B., and Kast W.M. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Res 67 (2007) 1344-1351
-
(2007)
Cancer Res
, vol.67
, pp. 1344-1351
-
-
Garcia-Hernandez Mde, L.1
Gray, A.2
Hubby, B.3
Kast, W.M.4
-
36
-
-
21544454118
-
The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis
-
Skinner M.A., Wedlock D.N., de Lisle G.W., Cooke M.M., Tascon R.E., Ferraz J.C., Lowrie D.B., Vordermeier H.M., Hewinson R.G., and Buddle B.M. The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. Infect Immun 73 (2005) 4441-4444
-
(2005)
Infect Immun
, vol.73
, pp. 4441-4444
-
-
Skinner, M.A.1
Wedlock, D.N.2
de Lisle, G.W.3
Cooke, M.M.4
Tascon, R.E.5
Ferraz, J.C.6
Lowrie, D.B.7
Vordermeier, H.M.8
Hewinson, R.G.9
Buddle, B.M.10
-
37
-
-
0142231018
-
Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost
-
The order of prime-boost with DNA and adenovirus vector vaccines is important for the induction of cell-mediated immune responses against HCV E2 antigen.
-
Park S.H., Yang S.H., Lee C.G., Youn J.W., Chang J., and Sung Y.C. Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21 (2003) 4555-4564. The order of prime-boost with DNA and adenovirus vector vaccines is important for the induction of cell-mediated immune responses against HCV E2 antigen.
-
(2003)
Vaccine
, vol.21
, pp. 4555-4564
-
-
Park, S.H.1
Yang, S.H.2
Lee, C.G.3
Youn, J.W.4
Chang, J.5
Sung, Y.C.6
-
38
-
-
47749129289
-
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination
-
Including a DNA priming protein boost immunization was able to elicit conformation sensitive antibody responses when compared to protein alone HIV-1 Env vaccine.
-
Vaine M., Wang S., Crooks E.T., Jiang P., Montefiori D.C., Binley J., and Lu S. Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination. J Virol 82 (2008) 7369-7378. Including a DNA priming protein boost immunization was able to elicit conformation sensitive antibody responses when compared to protein alone HIV-1 Env vaccine.
-
(2008)
J Virol
, vol.82
, pp. 7369-7378
-
-
Vaine, M.1
Wang, S.2
Crooks, E.T.3
Jiang, P.4
Montefiori, D.C.5
Binley, J.6
Lu, S.7
-
39
-
-
20744438004
-
Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins
-
Otten G.R., Schaefer M., Doe B., Liu H., Srivastava I., Megede J., Kazzaz J., Lian Y., Singh M., Ugozzoli M., et al. Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins. J Virol 79 (2005) 8189-8200
-
(2005)
J Virol
, vol.79
, pp. 8189-8200
-
-
Otten, G.R.1
Schaefer, M.2
Doe, B.3
Liu, H.4
Srivastava, I.5
Megede, J.6
Kazzaz, J.7
Lian, Y.8
Singh, M.9
Ugozzoli, M.10
|